Haematological Diseases
Haematological diseases
are disorders affecting the blood, blood-forming organs, or components of the
blood such as red blood cells (RBCs), white blood cells, platelets, and plasma
proteins. These disorders may result from abnormalities in the production,
structure, function, or destruction of blood cells. Anaemia is one of the
most common haematological disorders and occurs when the blood has an
inadequate capacity to carry oxygen, usually because of reduced haemoglobin
concentration or RBC mass.
Common causes of anaemia
include nutritional deficiencies, genetic abnormalities, chronic diseases,
blood loss, and increased destruction of RBCs. Important haematological
disorders discussed in this chapter include iron deficiency anaemia,
megaloblastic anaemia, sickle cell anaemia, thalassemia, hereditary and
acquired anaemias, and haemophilia.
1. Anaemia
Anaemia
is a condition characterized by a reduction in haemoglobin concentration,
haematocrit, or RBC mass below the normal range for the individual’s age and
sex. Because haemoglobin is responsible for carrying oxygen, anaemia can reduce
oxygen delivery to tissues.
Common manifestations of
anaemia
The clinical features depend
on the severity and rate of development of anaemia. Common symptoms include:
·
Fatigue and weakness
·
Pallor of skin and mucous
membranes
·
Shortness of breath,
particularly on exertion
·
Dizziness or headache
·
Palpitations
·
Reduced exercise tolerance
·
Cold hands and feet
·
Poor concentration
Severe or rapidly developing
anaemia may cause tachycardia, chest discomfort, breathlessness, and tissue
hypoxia.
2. Classification of Anaemia
Anaemia can be classified
according to the size of RBCs (mean corpuscular volume, MCV) or
according to its underlying cause.
|
Type |
MCV |
Common examples |
|
Microcytic anaemia |
<80 fL |
Iron deficiency anaemia, thalassemia |
|
Normocytic anaemia |
80–100 fL |
Acute blood loss, chronic disease, haemolysis |
|
Macrocytic anaemia |
>100 fL |
Vitamin B12 deficiency, folate deficiency |
Another useful classification
is based on the mechanism:
·
Decreased RBC production
·
Increased RBC destruction
(haemolysis)
·
Blood loss
3. Iron Deficiency Anaemia
Iron deficiency anaemia (IDA)
is the most common nutritional deficiency anaemia worldwide. Iron is essential
for the synthesis of haemoglobin, and inadequate iron availability results in
reduced haemoglobin production.
The developing RBCs become
progressively smaller and contain less haemoglobin, producing a microcytic,
hypochromic anaemia.
Causes
Iron deficiency may occur
because of:
·
Inadequate dietary iron intake
·
Increased iron requirements
during growth
·
Pregnancy
·
Chronic blood loss
·
Menstrual blood loss
·
Gastrointestinal bleeding
·
Malabsorption
·
Repeated blood donation
Pathophysiology
The development of iron
deficiency can be understood as a progressive process:
Reduced iron intake/absorption
or increased iron loss
↓
Depletion of iron stores
↓
Reduced serum iron availability
↓
Reduced haemoglobin synthesis
↓
Small, pale RBCs
↓
Reduced oxygen-carrying capacity
↓
Symptoms of anaemia
Initially, body iron stores
decrease without obvious anaemia. As deficiency progresses, haemoglobin
synthesis becomes impaired and microcytic, hypochromic RBCs develop.
Clinical features
In addition to general
features of anaemia, patients may develop:
·
Brittle nails
·
Hair loss
·
Glossitis
·
Angular cheilitis
·
Pica
·
Reduced concentration and work
capacity
Laboratory findings
Typical findings include:
·
Low haemoglobin
·
Low MCV
·
Low MCH
·
Low serum ferritin
·
Low serum iron
·
Increased total iron-binding
capacity (TIBC)
·
Increased transferrin
·
Increased red cell
distribution width (RDW)
Serum ferritin
generally reflects body iron stores, although ferritin may increase during
inflammation because it is also an acute-phase protein.
4. Megaloblastic Anaemia
Megaloblastic anaemia
results from impaired DNA synthesis, leading to abnormal maturation of
developing RBC precursors in the bone marrow. The major nutritional causes are vitamin
B12 deficiency and folate deficiency.
The impaired DNA synthesis
produces large, immature precursor cells called megaloblasts.
Circulating RBCs are typically large, producing macrocytic anaemia.
Basic mechanism
Vitamin B12/Folate deficiency
↓
Impaired DNA synthesis
↓
Delayed nuclear maturation
↓
Abnormal megaloblastic maturation
↓
Macrocytic anaemia
5. Vitamin B12 Deficiency Anaemia
Vitamin B12 is required for
normal DNA synthesis and neurological function. It is obtained primarily from
animal-derived foods and is absorbed in the terminal ileum after binding to intrinsic
factor, which is produced by gastric parietal cells.
Causes of vitamin B12
deficiency
·
Poor dietary intake,
particularly in strict vegans without supplementation
·
Pernicious anaemia
·
Gastric surgery or severe
gastric disease
·
Ileal disease or resection
·
Malabsorption
·
Certain medications
·
Prolonged nutritional
deficiency
Pathophysiology
Vitamin B12 deficiency causes
defective DNA synthesis in rapidly dividing cells, particularly bone marrow
cells. This results in ineffective erythropoiesis and the formation of large abnormal
RBC precursors.
Vitamin B12 deficiency also
interferes with normal neurological metabolism. Therefore, neurological
manifestations may occur in addition to anaemia.
Clinical features
·
Fatigue
·
Pallor
·
Weakness
·
Glossitis
·
Loss of appetite
·
Weight loss
·
Numbness or tingling
·
Difficulty walking or balance
problems
·
Cognitive or neurological
changes in severe or prolonged deficiency
Neurological manifestations
are an important distinguishing feature of vitamin B12 deficiency.
Laboratory findings
·
Increased MCV
·
Reduced haemoglobin
·
Macro-ovalocytes
·
Hypersegmented neutrophils
·
Reduced serum vitamin B12
·
Increased methylmalonic acid
·
Increased homocysteine
6. Folate Deficiency Anaemia
Folate (vitamin B9)
is essential for DNA synthesis and normal cell division. Folate deficiency
produces megaloblastic anaemia similar to vitamin B12 deficiency but does not
typically cause the characteristic neurological injury associated with vitamin
B12 deficiency.
Causes
·
Poor dietary intake
·
Increased requirement during
pregnancy
·
Malabsorption
·
Alcohol use disorder
·
Certain medications that
interfere with folate metabolism
·
Chronic illnesses associated
with poor nutrition
Clinical features
·
Fatigue
·
Pallor
·
Weakness
·
Shortness of breath
·
Glossitis
·
Gastrointestinal symptoms
Laboratory findings
·
Macrocytic anaemia
·
Macro-ovalocytes
·
Hypersegmented neutrophils
·
Reduced serum or red-cell
folate
·
Increased homocysteine
·
Normal methylmalonic acid
|
Table
1: Vitamin B12 Deficiency vs Folate Deficiency |
||
|
Feature |
Vitamin
B12 deficiency |
Folate
deficiency |
|
Anaemia |
Megaloblastic |
Megaloblastic |
|
RBC
size |
Increased
MCV |
Increased
MCV |
|
DNA
synthesis |
Impaired |
Impaired |
|
Homocysteine |
Increased |
Increased |
|
Methylmalonic
acid |
Increased |
Normal
|
|
Neurological
manifestations |
May
occur |
Absent
|
|
Important
dietary sources |
Animal-derived
foods |
Green
leafy vegetables, legumes, fortified foods |
Clinical point:
Folate supplementation can improve the anaemia of vitamin B12 deficiency while
allowing neurological damage to progress. Therefore, vitamin B12 deficiency
should be appropriately excluded before treating unexplained megaloblastic
anaemia with folate alone.
7. Sickle Cell Anaemia
Sickle cell anaemia is an
inherited haemoglobin disorder caused by a mutation in the β-globin gene,
resulting in production of abnormal haemoglobin known as haemoglobin S (HbS).
When oxygen levels are low,
HbS can polymerize, causing RBCs to become rigid and adopt a characteristic sickle
or crescent shape.
Pathophysiology
HbS formation
↓
Deoxygenation
↓
HbS polymerization
↓
RBC sickling and rigidity
↓
Vaso-occlusion + haemolysis
↓
Tissue ischemia + chronic anaemia
Sickled RBCs have reduced
flexibility and may obstruct small blood vessels. They are also more
susceptible to premature destruction, producing chronic haemolytic anaemia.
Clinical features
·
Chronic anaemia
·
Fatigue and pallor
·
Recurrent painful
vaso-occlusive episodes
·
Increased susceptibility to
certain infections
·
Jaundice due to haemolysis
·
Acute chest syndrome
·
Splenic dysfunction
·
Stroke and other organ
complications
Factors that may precipitate
sickling
·
Dehydration
·
Hypoxia
·
Infection
·
Extreme physical stress
·
Acidosis
·
Cold exposure
Diagnosis
Diagnosis may involve:
·
Complete blood count
·
Peripheral blood smear
·
Haemoglobin analysis
·
Haemoglobin electrophoresis or
equivalent laboratory methods
·
Genetic testing when
appropriate
8. Thalassemia
Thalassemia
comprises inherited disorders characterized by reduced synthesis of one or more
globin chains of haemoglobin. The two major forms are α-thalassemia and
β-thalassemia.
Reduced globin production results
in defective haemoglobin synthesis and ineffective erythropoiesis. Increased
destruction of abnormal RBCs also contributes to anaemia.
Pathophysiology
Reduced globin-chain synthesis
↓
Reduced normal haemoglobin formation
↓
Ineffective erythropoiesis + haemolysis
↓
Chronic anaemia
↓
Increased erythropoietic drive and compensatory changes
Clinical features
Severity varies greatly
depending on the type and genotype.
·
Pallor
·
Fatigue
·
Jaundice
·
Splenomegaly
·
Growth retardation in severe
childhood disease
·
Bone changes due to increased
marrow activity
·
Iron overload in patients
receiving repeated transfusions
Major forms
|
Type |
General characteristic |
|
α-thalassemia |
Reduced α-globin production |
|
β-thalassemia |
Reduced β-globin production |
|
Thalassemia
trait |
Usually mild or asymptomatic
anaemia |
|
Severe
thalassemia |
May require regular
transfusion and specialized care |
Important distinction from iron deficiency
Both iron deficiency and
thalassemia can produce microcytic anaemia, but iron studies and
haemoglobin analysis help distinguish them. Iron supplementation should not be
given routinely to a person with thalassemia unless iron deficiency has been
demonstrated.
9. Hereditary Anaemias
Hereditary anaemias
are anaemias caused by inherited genetic abnormalities affecting haemoglobin,
RBC membrane proteins, or enzymes required for RBC survival.
Important examples include:
·
Sickle cell anaemia
·
Thalassemia
·
Hereditary spherocytosis
·
Glucose-6-phosphate
dehydrogenase (G6PD) deficiency
·
Other inherited RBC enzyme or
membrane disorders
General mechanism
Genetic defect
↓
Abnormal haemoglobin, membrane, or RBC enzyme
↓
Reduced RBC survival and/or abnormal RBC structure
↓
Anaemia
Some hereditary anaemias are
predominantly haemolytic, while others result mainly from ineffective
RBC production.
10. Acquired Anaemias
Acquired anaemias
develop during a person’s lifetime and are not directly caused by an inherited
genetic abnormality.
Common causes include:
·
Iron deficiency
·
Vitamin B12 or folate deficiency
·
Chronic kidney disease
·
Chronic inflammatory diseases
·
Acute or chronic blood loss
·
Autoimmune haemolysis
·
Drug-induced haemolysis
·
Bone marrow disorders
·
Endocrine and systemic
diseases
General mechanisms
Acquired anaemia may develop
through:
Reduced RBC production
or
Increased RBC destruction
or
Blood loss
|
Table
2: Hereditary and Acquired Anaemia: Comparison |
||
|
Feature |
Hereditary
anaemia |
Acquired
anaemia |
|
Basic
cause |
Genetic
abnormality |
Develops
after birth due to various causes |
|
Examples |
Sickle
cell disease, thalassemia, hereditary spherocytosis |
Iron
deficiency, B12 deficiency, chronic disease |
|
Onset |
Often
early, but variable |
Variable |
|
Family
history |
May
be present |
Absent
|
|
Treatment |
Depends
on specific genetic disorder |
Treat
underlying cause |
|
Prevention |
Genetic
counselling and screening may help |
Often
depends on prevention of underlying cause |
11. Haemophilia
Haemophilia is an inherited
bleeding disorder caused by deficiency or dysfunction of specific coagulation
factors. The two major forms are haemophilia A and haemophilia B.
·
Haemophilia A:
Factor VIII deficiency
·
Haemophilia B:
Factor IX deficiency
Both affect the intrinsic
pathway of coagulation and result in impaired thrombin generation and
fibrin clot formation.
Pathophysiology
Factor VIII or IX deficiency
↓
Impaired intrinsic activity
↓
Reduced Factor X activation
↓
Reduced thrombin generation
↓
Reduced fibrin formation
↓
Impaired stable clot formation
↓
Prolonged bleeding
Clinical features
Haemophilia commonly produces deep
tissue and joint bleeding, rather than only superficial bleeding.
Important manifestations
include:
·
Prolonged bleeding after
injury or procedures
·
Recurrent joint bleeding (haemarthrosis)
·
Muscle haematomas
·
Easy bruising
·
Deep tissue bleeding
·
Intracranial bleeding in
severe cases
Repeated bleeding into joints
can cause chronic joint damage.
Laboratory findings
Typical findings include:
·
Prolonged activated partial
thromboplastin time (aPTT)
·
Usually normal prothrombin
time (PT)
·
Platelet count generally
normal
·
Reduced activity of the
affected clotting factor
Inheritance
Classical haemophilia A and B
are usually X-linked recessive disorders and therefore occur
predominantly in males, while females may be carriers or, less commonly,
affected under specific genetic circumstances.
Treatment
Management depends on disease
severity and clinical circumstances and may include:
·
Replacement of the deficient
clotting factor
·
Recombinant factor
concentrates
·
Desmopressin (DDAVP)
in selected patients with mild haemophilia A
·
Antifibrinolytic agents for
selected mucosal bleeding
·
Non-factor therapies such as emicizumab
for appropriate patients with haemophilia A
|
Table
3: Comparison
of Major Haematological Disorders |
|||
|
Disorder |
Primary
defect |
Main
type |
Characteristic
feature |
|
Iron
deficiency anaemia |
Iron
deficiency |
Microcytic |
Reduced
haemoglobin synthesis |
|
Vitamin
B12 deficiency |
B12
deficiency |
Macrocytic/megaloblastic |
Neurological
manifestations may occur |
|
Folate
deficiency |
Folate
deficiency |
Macrocytic/megaloblastic |
No
typical neurological involvement |
|
Sickle
cell anaemia |
HbS
production |
Haemolytic |
Sickling
and vaso-occlusion |
|
Thalassemia |
Reduced
globin synthesis |
Microcytic/haemolytic |
Ineffective
erythropoiesis |
|
Hereditary
spherocytosis |
RBC
membrane defect |
Haemolytic |
Spherocytes
and haemolysis |
|
G6PD
deficiency |
RBC
enzyme deficiency |
Haemolytic |
Episodic
haemolysis after oxidative stress |
|
Haemophilia
A |
Factor
VIII deficiency |
Bleeding
disorder |
Deep
bleeding and haemarthrosis |
|
Haemophilia
B |
Factor
IX deficiency |
Bleeding
disorder |
Deep
bleeding and haemarthrosis |
12. Key Laboratory Investigations
Laboratory investigations help
identify the type and cause of a haematological disorder.
Common investigations
·
Complete blood count (CBC):
Measures haemoglobin, RBC indices, WBC count, and platelet count.
·
Peripheral blood smear:
Provides information about RBC size, shape, colour, and abnormal cells.
·
Reticulocyte count:
Helps assess bone marrow response to anaemia.
·
Serum ferritin and iron
studies: Useful in evaluating iron status.
·
Vitamin B12 and folate levels:
Help investigate macrocytic anaemia.
·
Haemoglobin analysis:
Important in suspected sickle cell disease and thalassemia.
·
Coagulation tests:
PT/INR and aPTT help evaluate clotting disorders.
·
Specific factor assays:
Used to identify coagulation factor deficiencies such as haemophilia.
|
Table
4: High-Yield
Clinical Comparison |
||||
|
Feature |
Iron Deficiency |
B12/Folate Deficiency |
Sickle Cell Anaemia |
Thalassemia |
|
RBC
size |
Small |
Large |
Normocytic
|
Small |
|
Main
defect |
Iron
deficiency |
Impaired
DNA synthesis |
Abnormal
HbS |
Reduced
globin synthesis |
|
Haemolysis |
Absent
|
Ineffective
erythropoiesis |
Prominent |
Variable/prominent |
|
Neurological
signs |
No |
B12: Yes |
Not
characteristic |
Not
characteristic |
|
Genetic |
No |
Usually
acquired |
Yes |
Yes |
|
Major
complication |
Tissue
hypoxia |
Neurological
damage in B12 deficiency |
Vaso-occlusion |
Iron
overload in transfusion-dependent disease |

With a foundation in pharmacology, I am engaged in both teaching and research. My work has been published in reputed national and international journals, and I actively participate in scientific conferences to share findings and stay connected with emerging advancements. Thank you for visiting. Your interest is truly appreciated.
